N G Industries Ltd
Incorporated in 1994, N G Industries Ltd is in
the business of providing healthcare services[1]
- Market Cap ₹ 38.8 Cr.
- Current Price ₹ 116
- High / Low ₹ 162 / 111
- Stock P/E 20.1
- Book Value ₹ 100
- Dividend Yield 3.02 %
- ROCE 5.88 %
- ROE 4.80 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 1.16 times its book value
- Stock is providing a good dividend yield of 3.02%.
Cons
- The company has delivered a poor sales growth of 6.65% over past five years.
- Company has a low return on equity of 2.00% over last 3 years.
- Earnings include an other income of Rs.1.13 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.86 | 16.93 | 17.28 | 17.36 | 17.67 | 18.50 | 11.88 | 18.42 | 18.70 | 16.88 | 16.55 | 16.39 | 16.91 | |
| 12.20 | 13.80 | 14.40 | 14.30 | 14.85 | 15.71 | 10.62 | 16.06 | 16.81 | 14.87 | 14.70 | 14.61 | 15.04 | |
| Operating Profit | 2.66 | 3.13 | 2.88 | 3.06 | 2.82 | 2.79 | 1.26 | 2.36 | 1.89 | 2.01 | 1.85 | 1.78 | 1.87 |
| OPM % | 17.90% | 18.49% | 16.67% | 17.63% | 15.96% | 15.08% | 10.61% | 12.81% | 10.11% | 11.91% | 11.18% | 10.86% | 11.06% |
| 0.53 | -0.07 | -0.02 | -0.24 | -0.34 | -0.05 | 0.14 | 1.63 | 8.37 | 4.51 | 8.00 | 1.03 | 1.13 | |
| Interest | 0.04 | 0.06 | 0.07 | 0.08 | 0.18 | 0.16 | 0.08 | 0.09 | 0.09 | 0.07 | 0.10 | 0.07 | 0.05 |
| Depreciation | 1.19 | 0.58 | 0.57 | 0.60 | 0.57 | 0.56 | 0.49 | 0.58 | 0.52 | 0.60 | 0.61 | 0.59 | 0.57 |
| Profit before tax | 1.96 | 2.42 | 2.22 | 2.14 | 1.73 | 2.02 | 0.83 | 3.32 | 9.65 | 5.85 | 9.14 | 2.15 | 2.38 |
| Tax % | 27.04% | 36.78% | 36.04% | 34.11% | 34.68% | 27.72% | 25.30% | 21.39% | 13.78% | 14.02% | 15.43% | 19.07% | |
| 1.43 | 1.53 | 1.42 | 1.41 | 1.12 | 1.47 | 0.61 | 2.61 | 8.32 | 5.03 | 7.74 | 1.73 | 1.93 | |
| EPS in Rs | 4.27 | 4.57 | 4.24 | 4.21 | 3.34 | 4.39 | 1.82 | 7.79 | 24.83 | 15.01 | 23.10 | 5.16 | 5.75 |
| Dividend Payout % | 81.99% | 76.63% | 82.57% | 83.16% | 104.69% | 0.00% | 0.00% | 44.92% | 14.09% | 0.00% | 0.00% | 67.77% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 7% |
| 3 Years: | -4% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | 7% |
| TTM: | -74% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 20% |
| 3 Years: | 0% |
| 1 Year: | -23% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| Last Year: | 5% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 | 3.35 |
| Reserves | 10.99 | 11.11 | 8.97 | 8.50 | 7.62 | 5.99 | 11.66 | 20.56 | 24.85 | 32.79 | 35.17 | 30.21 |
| 1.07 | 1.17 | 1.91 | 1.48 | 1.25 | 3.02 | 0.27 | 0.51 | 0.59 | 1.18 | 1.78 | 1.61 | |
| 1.56 | 1.58 | 0.15 | 0.26 | 1.10 | 1.55 | 1.78 | 2.74 | 1.93 | 2.60 | 1.32 | 0.30 | |
| Total Liabilities | 16.97 | 17.21 | 14.38 | 13.59 | 13.32 | 13.91 | 17.06 | 27.16 | 30.72 | 39.92 | 41.62 | 35.47 |
| 5.09 | 4.87 | 4.90 | 4.96 | 5.16 | 5.26 | 5.35 | 5.56 | 5.19 | 5.62 | 5.64 | 5.13 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 8.40 | 8.89 | 4.30 | 4.24 | 3.37 | 3.84 | 8.16 | 16.15 | 22.27 | 28.95 | 31.93 | 25.98 |
| 3.48 | 3.45 | 5.18 | 4.39 | 4.79 | 4.81 | 3.55 | 5.45 | 3.26 | 5.35 | 4.05 | 4.36 | |
| Total Assets | 16.97 | 17.21 | 14.38 | 13.59 | 13.32 | 13.91 | 17.06 | 27.16 | 30.72 | 39.92 | 41.62 | 35.47 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.77 | 2.01 | 1.85 | 2.43 | 3.82 | 2.85 | 1.35 | -1.73 | 3.16 | -1.02 | 1.81 | 0.96 | |
| -0.62 | -0.92 | -0.89 | -1.50 | -1.09 | -3.41 | 2.00 | 1.26 | -1.72 | 2.25 | -1.23 | -0.49 | |
| -2.16 | -1.30 | -0.68 | -1.84 | -1.75 | 0.27 | -2.78 | 0.22 | -1.11 | -0.60 | -0.62 | -1.42 | |
| Net Cash Flow | -1.01 | -0.21 | 0.28 | -0.91 | 0.99 | -0.29 | 0.57 | -0.25 | 0.33 | 0.63 | -0.03 | -0.95 |
| Free Cash Flow | 1.49 | 1.65 | 1.25 | 1.77 | 3.04 | 2.19 | 0.77 | -2.52 | 3.02 | -2.04 | 1.16 | 0.87 |
| CFO/OP | 92% | 90% | 90% | 99% | 160% | 124% | 121% | -51% | 236% | -10% | 171% | 80% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 4.67 | 6.47 | 8.87 | 9.67 | 10.74 | 9.27 | 10.14 | 15.46 | 1.37 | 3.24 | 9.48 | 10.69 |
| Inventory Days | 54.21 | 55.81 | 61.32 | 58.24 | 53.13 | 41.48 | 64.81 | 155.87 | 34.69 | 52.74 | 63.96 | 69.93 |
| Days Payable | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 58.87 | 62.28 | 70.19 | 67.92 | 63.87 | 50.75 | 74.95 | 171.33 | 36.05 | 55.98 | 73.44 | 80.62 |
| Working Capital Days | -43.72 | -34.93 | -14.57 | -8.41 | -19.00 | -67.08 | -32.87 | 10.50 | -24.79 | 19.24 | -20.95 | -7.79 |
| ROCE % | 11.08% | 17.98% | 16.68% | 18.80% | 18.71% | 19.77% | 6.87% | 10.68% | 6.58% | 6.56% | 5.69% | 5.88% |
Insights
In beta| Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Permanent employees (excluding Whole-time Director) count |
|
||||||
| Diagnostic Centre & Pathological Laboratory - share of total turnover % |
|||||||
| Hospital Activities - share of total turnover % |
|||||||
| Retail Pharmacy - share of total turnover % |
|||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- Newspaper Publication of Unaudited Financial Results for quarter ended June 30, 2026
-
Board Meeting Outcome for Unaudited Financial Results For Quarter Ended June 30, 2026
- N G Industries announced Q1 FY2026-27 unaudited results; profit rose to Rs 38.8 lakh, sales Rs 421.0 lakh.
-
Unaudited Financial Results For Quarter Ended June 30, 2026
- N G Industries announced Q1 FY2026-27 unaudited results; profit rose to Rs 38.8 lakh, board approved.
-
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For Quarter Ended June 30, 2026
- Board meeting on 13 August 2026 to approve Q1 FY27 unaudited financial results.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Annual reports
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2011
from bse
Business Overview:[1]
NGIL is in the healthcare business which
includes Doctor Clinics, Outpatient Services,
Diagnostic Laboratory and other Diagnostic Services, an Indoor Facility with wards and
ICU, Surgical Infrastructure, Dialysis Services, Special Clinics like Infertility, Retail Pharmacy,
Home Care Services, and an Adult Vaccination Unit